Back

Early Prophylactic Hydrocortisone and Survival Without Bronchopulmonary Dysplasia in Extremely Preterm Infants.

2025-07-21 pediatrics Title + abstract only
View on medRxiv
Show abstract

ImportanceIn randomized trials, early prophylactic low-dose hydrocortisone improved survival without bronchopulmonary dysplasia (BPD) and had few adverse effects in extremely preterm infants. Large scale implementation data are needed to estimate effect size and safety. ObjectiveTo examine the association between early prophylactic hydrocortisone and survival without BPD at 36 weeks postmenstrual age in extremely preterm infants in Sweden after implementation, and to assess the safety of this t...

Predicted journal destinations